Welcome to Thinta Diagnostics
Thinta Diagnostics is a Cape Town based healthcare firm focused on non-invasive medical diagnostics. With a highly skilled management team consisting of a professor of biomedical engineering, a finance professional and a biomedical engineer with extensive industry experience, Thinta is positioned to have an extremely high social impact throughout Africa with its life-saving technologies targeted toward women and children.
Thinta received its seed funding from PATH, a global health nonprofit located in Seattle, and receives support from the South African Medical Research Council. A strong management team, valuable partnerships, innovative technology, and an extremely strong financial proposition, Thinta Diagnostics is an ideal candidate for either social grant funding or investment funding.
Follow Our Progress
The Management Team
Martin Weiss MSc (Biomed Eng) | Chief Technical Officer
Martin has been in the telecoms industry for over 30 years, and has extensive experience in electronic design and product development within the instrumentation and telecoms fields. Martin’s qualifications include a BSC Electronic Engineering and a Masters in Medicine (Biomed). Martin’s experience places him at the forefront of innovation in digital health in South Africa.
Dr. Dayne Morkel PhD, MBA, CFA | Chief Executive Officer
Dayne Morkel began his career in investment banking at Morgan Stanley in New York, and has subsequently held Chief Financial Officer and Chief Executive Officer roles at various organizations, most recently leading a Bill & Melinda Gates Foundation-funded initiative to drive global health innovation in Africa. Professor Morkel is now President & CEO of a US-based Foundation, and serves on the board of several start-up, healthcare, and non-profit companies. Professor Morkel holds a Ph.D. and MBA, and is a CFA Charterholder.
Dr. Tony Bunn PhD | Founder & Chairperson
Tony Bunn was previously head of the department of biomedical engineering at the University of Cape Town and currently holds an honorary professorship with the university. He is also an extraordinary professor at the Central University of Technology and is the current director of the MRC-PATH Global Health Innovation Accelerator. Professor Bunn research has led to the establishment of five successful, local start-up health technology companies and one international company.